XenoPort XNPT
-
5 Biotechnology Stocks With Upcoming Catalysts
By Helix Investment Management : Of all the sectors in the stock market, no sector moves more due to corporate developments than the biotechnology sector. A single drug trial or FDA decision can send stocks soaring, or plunging. Due to this trend, many investors choose to trade biotechnology stocks
-
Selling An FDA Approval: Recent Results
By BinaryLeverage : In March I wrote an article investigating the "sell the news" effect in small biotech stocks. The news in question was the announcement of an FDA approval for an investigational drug. At the time I reviewed the relevant approvals from 2011 and early 2012. The article reviewed ...
-
End Of Week Bio-Pharma Catalyst Trade And Watch List
By Scott Matusow : Below is an overview of what I feel are the catalyst trades with the most short term potential that I mentioned in some of my articles over the last week. I strongly feel all the stocks mentioned below have a great shot at seeing some nice short term price appreciation. Celldex (
-
6 Biotech Stocks With Huge Potential In June
By StockPandit : So far, 2012 has been the best year for the biotechnology and drugs industry. So many stocks surged in the last four months based on clinical trial results, FDA approval, FDA advisory committee recommendation, European commission approval, recommendation from independent ...
-
Wednesday, April 18th Bio-Pharma Mover Watch List
By Scott Matusow : I believe the following stocks could be on the upside move, today, Wednesday April 18th, 2012, which could make for a nice short term gain for those who prefer short term swing trading. Achillion ( ACHN) Achillion will be releasing results of its Phase IIa clinical trials of ...
-
Xenoport More Interesting After Washed Out Expectations
… launch of Benlysta in lupus, but XenoPort ( XNPT ) too has seen some serious disappointment ..... launch of its drug Horizant. While XenoPort 's lead drugs are unlikely to ..... Cost-Benefit Is Central to the XenoPort story today is the thus far disappointing …
-
Bio-Pharma Catalyst Trades That Offer Decent Short-Term Gains
By Scott Matusow : Below I have listed a few bio-pharma catalyst trades I feel offer traders a good shot at some decent short term gains. I have written a full feature article on the last company on this list that I feel offers very high speculative long term multi-bagger opportunity. GTX ( GTXI)
-
Focus On Upcoming FDA Drug Approval And Advisory Dates
… possible dips below your average price, buying on those dips can be a good proposition as well, in my opinion. Xenoport ( XNPT ) focuses on developing and commercializing internally discovered product candidates that utilize the body's natural …
-
XenoPort ( XNPT ): Q4 EPS of -$0.48 misses by $0.09. Revenue of $5.3M (+181.7% Y/Y). (PR)
XenoPort ( XNPT ): Q4 EPS of -$0.48 misses by $0.09 . Revenue of $5.3M (+181.7% Y/Y). ( PR ) Post your comment!
-
XenoPort , Inc. XNPT Q4 2011 Earnings Call Transcript
… My name is Jessica, and I will be your conference operator today. At this time, I would like to welcome everyone to the XenoPort Fourth Quarter Financial Results Conference Call. All lines have been placed on mute to prevent any background noise. After …